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6-Hydroximino-4-aza-A-homo-cholest-3-one and related analogue as a potent
inducer of apoptosis in cancer cells
Yanmin Huang , Jianguo Cui , Qiaoxia Zheng , Chun Zeng , Quan Chen , Aimin Zhou
Introduction
The synthesis of some aza homosteroid compounds with unu
sual and interesting structures has been reported recently [1 4].
These compounds exhibit valuable biological activities such as
cytotoxicity and antibacteria. Study of aza homosteroids indicates
that the presence of the characteristic group ( NH CO ) in the aza
homosteroid molecule has been demonstrated to be important in
lowering toxicity and improving anti tumor activity of the com
pounds in cancer treatment [5].
Recently we designed and synthesized several new steroidal
lactams with the introduction of N atom on A or D ring. Our re
sults have shown that these compounds displayed a distinct cyto
toxicity against different cancer cell types [6,7]. In this study, we
report that 6 hydroximino 4 aza A homo cholest 3 one (1) and
6 hydroxyl 4 aza A homo cholest 3 one (2), new steroidal lac
tams were synthesized recently [8], exerted potent cytotoxic activ
ity against several cancer cells including HT 29 (colorectal
adenocarcinoma), GNE 2 (nasopharyngeal carcinoma), SPC A (lung
carcinoma), Tu 686 (laryngocarcinoma) and PC 3 (prostate adeno
carcinoma) cancer cells. Further investigation revealed that the
compounds were able to induce cancer cell apoptosis and inhibited
tumor growth in athymic mice.
Materials and methods
Drug preparations
The tested compounds (Fig. 1) were synthesized by previously
described methods [8]. Stock solutions of the tested compounds
were made immediately before use.
Biological assays
Cell culture and assay for cell viability
GNE 2 (nasopharyngeal carcinoma), SPC A (lung carcinoma)
and Tu 686 (laryngic carcinoma) cell lines were obtained by
Guangxi Medical University (China); HT 29 (colorectal adenocarci
noma) and PC 3 (prostate adenocarcinoma) cancer cells were ob
tained by ATCC, Manassas, VA. Cells were grown in RPMI 1640
supplemented with 10% cosmic calf serum (Hyclone) and antibiot
ics in a humidiﬁed atmosphere of 5% CO2 at 37 C. The viability of
these cells was determined using the colorimetric CellTiter 96
aqueous Cell Proliferation Assay (MTT) according to the instruc
tions provided by the manufacturer (Promega, Madison, WI).
Brieﬂy, cells (1 3  104 cells per well) were seeded in 96 wells
plates. One day after seeding, the cells were treated with or with
out different concentration of each compound and reincubated for
72 h. After the cells were washed with sterile phosphate buffer sal
ine (PBS), 190 lL of RPMI 1640 and 10 lL of the tetrazolium dye
(MTT) (5 mg/mL) solution were added to each well, and the cells
were incubated for an additional 4 h. The medium was discarded;
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manufacturer’s instructions. MTT [3 (4, 5 dimethylthiazol 2 yl) 2,
5 diphenyl tetrazolium bromide] is a compound that can be taken
up by viable cells and reduced by a mitochondrial dehydrogenase
forming a formazan product in living cells. The absorbance of the
formazan product at 492 nm is in linear proportion to cell num
bers. The results were summarized as IC50 values in lmol/L in Ta
ble 1. Apparently the compound 1 and 2 displayed a distinct
antiproliferative function on these cancer cells.
Compounds 1 and 2 induce apoptosis in cancer cells
To determine the molecular mechanism by which the com
pound 1 and 2 inhibit cancer cell proliferation, we further analyzed
the cytotoxicity of the compound 1 and 2 in PC 3 cells. As shown in
Fig. 2, both compound 1 and 2 induced PC 3 cell death could be
clearly observed. To determine whether the decreased viability of
PC 3 cells was due to the compound 1 or 2 induced apoptosis,
the cells were treated with the compound 1 or 2, and subjected
to Annexin V analysis. The translocation of membrane phospho
lipid phosphatidylserine (PS) from the inner to the outer leaﬂet
of the plasma membrane is an early event of cell apoptosis.
Annexin V is a 35 36 kD Ca2+ dependent, phospholipid binding
protein that has a high afﬁnity for PS. Therefore, FITC conjugated
Annexin V is commonly used to determine apoptotic cells at an
early stage. As shown in Fig. 3, treatment with compound 1 and
2 resulted in 35.2% and 61.5% PI/Annexin V double labeled apopto
tic cells after 24 h incubation, suggesting both compounds are a
potent apoptotic inducer in prostate cancer cells. The similar result
was observed after PC3 cells were treated with compound 1 and 2
in a dose dependent manner (Fig. 4). Treatment with 10 lg/mL of
compound 1 for 24 h resulted in 42.2% PI/Annexin V double la
beled apoptotic cells while compound 2 could produce 66.4% on
the same condition, suggesting the compound 2 is more potent
in induction of apoptosis in PC 3 cells.
To further evaluate compound 1 induced apoptosis in prostate
cancer cells, we determined the activity of caspase 3 in the cells
by a ﬂow cytometry assay. Majority of the cells (81.28%) after
24 h treatment with the compound 1 exerted caspase 3 activity
(Fig. 5).
Cytochrome c is an electron transporting protein within the in
ter membrane space of the mitochondria. It has been demon
strated that cytochrome c plays an important role in apoptotic
Fig. 3. Compound 1 and 2 inducing apoptosis in PC-3 cells is time-dependent PC-3 cells were treated with 10 lg/mL of either compound 1 or 2 for 0, 12 and 24 h and
subjected to Annexin V and PI double staining.
Fig. 2. Photographs of the unstained cells were taken under Olympus model CKX31 at 100magniﬁcation after treatment of PC-3 cells with various doses of compound 1 or 2
for 48 h.
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the intracellular portion of the receptor, resulting in the activation
of caspase 8 and 3 the effector enzymes in cell apoptosis. The
intrinsic apoptotic pathway is characterized by permeabilization
of the mitochondria in the injured cells, resulting in release of cyto
chrome c into the cytoplasm. Cytochrome c then forms a multi
protein complex known as the ‘apoptosome’ and initiates activa
tion of the caspase cascade through caspase 9. Activated caspase
9 cleaves and activates caspase 3, leading to apoptosis. Our results
implicate that the compound 1 may induce apoptosis in PC 3 cells
through activation of the intrinsic pathway although the exact
molecular mechanism remains to be further elucidated.
Inhibitory effect on the growth of xenografted tumors
Clearly, compound 1 is able to induce apoptosis in prostate can
cer cells. The potential to be a drug candidate is dependent of the
effectiveness on tumor growth in vivo. To determine the therapeutic
role of the compound 1 in tumor growth, PC 3 cells were implanted
on the back near anterior limbs as described in the experimental
section. The compound 1 dissolved in DMSO and diluted in PBS con
taining 1% Tween 80 was intraperitoneally injected at the lower
abdomen with 10 mg/kg body weight per day for ﬁve consecutive
days. Obviously the compound was effective. The tumors on the
mice treated with compound 1 were signiﬁcantly growing slower.
After termination of the experiment, the tumors were excised and
weighed. As shown in Fig. 7A C, the average weight of tumors from
mice treatedwith compound 1was about 5.8 fold smaller than that
in the controlmice. The result suggests compound1maybe a potent
drug candidate for treating prostate cancer.
Conclusion
The antiproliferative activity of the new steroidal lactam 6
hydroximino 4 aza A homo cholest 3 one(1) and 6 hydroxyl 4
aza A homo cholest 3 one(2) against several cancer cell types
was investigated. Our results revealed that the steroidal lactam
compounds 1 and 2 displayed a distinct cytotoxicity against these
cancer cells through effectively inducing cancer cell apoptosis by
activation of the intrinsic pathway. Furthermore, the compound
1 inhibited tumor growth in an athymic mouse model, suggesting
a potential for the compound to be a therapeutic drug candidate for
prostate cancer treatment.
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